Europe
The companies will work to discover, develop and commercialize novel therapies that modulate G protein-coupled receptor (GPCR) targets that AbbVie selects.
Enterome SA, based in Paris and Cambridge, Massachusetts, announced a new financing totaling $52.6 million (€46.3 million). This was a Series E round.
Biopharma and life sciences companies provide updates on their pipelines and business plans.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 24, 2020.
Relugolix is a once-daily, oral gonadotropin-releasing hormone (GnRH) receptor antagonist.
Sanofi Pasteur and Translate Bio announced the expansion of an existing collaboration to develop mRNA vaccines for infectious diseases. The original deal was entered in 2018.
It will focus on building new life sciences companies coming out of research in the UK, including spinouts from universities.
The TACTIC-E trial will investigate the safety and efficacy of experimental therapies designed to prevent and treat life-threatening complications associated with COVID-19 in hospitalized patients who are at early stages of the disease.
Interactive data rapidly available on state, region or county level
Rentschler Biopharma SE, a leading global contract development and manufacturing organization for biopharmaceuticals, announced the appointment of Alexander Dettmer as Chief Financial Officer, effective July 1, 2020.
PRESS RELEASES